Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-07-19 Sale |
2024-07-23 5:04 pm |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D AND CSO |
129,206 | $7.6505 | $988,495 | 31,317 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-19 11:12 am |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D AND CSO |
41,783 | $6.9285 | $289,492 | 160,523 (Direct) |
View |
| 2024-07-16 Sale |
2024-07-17 6:11 pm |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D AND CSO |
50,000 | $7.13 | $356,500 | 202,306 (Direct) |
View |
| 2024-07-12 Sale |
2024-07-16 6:14 pm |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D AND CSO |
92,377 | $7.0425 | $650,563 | 252,306 (Direct) |
View |
| 2024-07-09 Sale |
2024-07-11 8:45 pm |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D AND CSO |
105,931 | $6.9526 | $736,500 | 344,683 (Direct) |
View |
| 2024-07-05 Sale |
2024-07-09 4:46 pm |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D AND CSO |
12,342 | $7.06 | $87,135 | 450,614 (Direct) |
View |
| 2024-07-03 Sale |
2024-07-03 2:42 pm |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D AND CSO |
50,000 | $6.76 | $338,000 | 473,154 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-07-01 Exercise |
2024-07-03 2:42 pm |
N/A 2031-02-25 |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D AND CSO |
7,649 | $0 | 473,154 (Direct) |
View |
| 2024-07-01 Exercise |
2024-07-03 2:42 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D AND CSO |
7,649 | $0.0002 | 473,154 (Direct) |
View |
| 2024-04-05 Exercise |
2024-04-08 5:33 pm |
N/A 2031-02-25 |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D AND CSO |
17,847 | $0 | 533,353 (Direct) |
View |
| 2024-04-05 Exercise |
2024-04-08 5:33 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D AND CSO |
17,847 | $0.0002 | 533,353 (Direct) |
View |
| 2023-09-20 Exercise |
2024-03-04 11:07 am |
N/A 2030-02-03 |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D AND CSO |
20,728 | $0 | 533,353 (Direct) |
View |
| 2023-09-20 Exercise |
2024-03-04 11:07 am |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D AND CSO |
5,431 | $0.002 | 533,353 (Direct) |
View |
| 2023-09-20 Exercise |
2024-03-04 11:07 am |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D AND CSO |
15,297 | $0.0002 | 533,353 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-14 5:04 pm |
N/A 2030-02-03 |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D and CSO |
316,410 | $0 | 533,353 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-14 5:04 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D and CSO |
255,219 | $0.002 | 533,353 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-14 5:04 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D and CSO |
61,191 | $0.0002 | 533,353 (Direct) |
View |
| 2022-10-31 Option Award |
2022-11-02 7:11 pm |
N/A 2032-10-30 |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D and CSO |
170,000 | $0 | 320,322 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 5:11 pm |
N/A 2032-01-26 |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie EVP, R&D and CSO |
170,000 | $0 | 170,000 (Direct) |
View |
Ownership |
2021-08-09 6:08 pm |
N/A N/A |
Eliem Therapeutics Inc. | ELYM | Morisset Valerie Chief Scientific Officer |
0 | $0 | 533,353 (Direct) |
View |